Primed Pharmaceuticals LLC v. Starr Indemnity & Liability Company
This text of Primed Pharmaceuticals LLC v. Starr Indemnity & Liability Company (Primed Pharmaceuticals LLC v. Starr Indemnity & Liability Company) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK PRIMED PHARMACEUTICALS, LLC,
Plaintiff,
-v- CIVIL ACTION NO.: 21 Civ. 1025 (PGG) (SLC)
STARR INDEMNITY & LIABILITY COMPANY, ORDER
Defendant.
SARAH L. CAVE, United States Magistrate Judge.
Pursuant to the Telephone Conference held today, August 23, 2021, the Court Orders as follows: 1) The letter-motion by Plaintiff Primed Pharmaceuticals, LLC (“Plaintiff”) to preclude discovery on extrinsic evidence supporting Defendant Starr Indemnity & Liability Company’s (“Starr”) prior publication exclusion (the “Motion” (ECF No. 32)) is GRANTED IN PART AND DENIED IN PART as set forth below. a. The Court will permit narrow discovery into extrinsic evidence concerning “advertising” and “advertising activities” by Primed before November 15, 2014. See Value Wholesale, Inc. v. KB Ins. Co., 450 F. Supp. 3d 292 (E.D.N.Y. 2020); Polarome Int’l, Inc. v. Greenwich Ins. Co., 404 N.J. Super. 241 (N.J. App. Div. 2008). Accordingly, the parties shall promptly meet and confer concerning the scope of discovery concerning Primed’s “advertising” and “advertising activities” prior to November 15, 2014, including (but not limited to): i. Deposition testimony and exhibits of Matthew Zeigler; ii. Statements concerning Primed in the Statement of Undisputed Facts, as well as exhibits concerning Primed; iii. Exhibits to the Reports of Dr. Gregory Bell. A Telephone Status Conference concerning the scope of discovery is scheduled Thursday, September 9, 2021 at 11:00 am on the Court’s conference line. The parties are not required to file a status report or letter in advance of the conference, but if they elect to do so, they shall submit a single filing, no longer than six pages, by Tuesday, September 7, 2021. The parties are directed to call: (866) 390-1828; access code: 380-9799, at the scheduled time. If following a meet and confer the parties agree concerning the scope of discovery, such that they believe this conference is no longer required, they may submit a joint application to cancel the conference at least 48 hours in advance. The Clerk of Court is respectfully directed to close ECF No. 32.
Dated: New York, New York August 23, 2021 SO ORDERED.
AUC CW, CABAH L. CAVE United States Magistrate Judge
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
Primed Pharmaceuticals LLC v. Starr Indemnity & Liability Company, Counsel Stack Legal Research, https://law.counselstack.com/opinion/primed-pharmaceuticals-llc-v-starr-indemnity-liability-company-nysd-2021.